Stockreport

Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]

Viridian Therapeutics, Inc.  (VRDN) 
PDF - Successful October submission of Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for veligrotug in thyroid eye disease (TED) and pr [Read more]